Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS
· Delayed Price · Currency is USD
1.000
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST
Mosaic ImmunoEngineering Employees
As of December 31, 2023, Mosaic ImmunoEngineering had 8 total employees, including 3 full-time and 5 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$177,416
Market Cap
4.42M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8 | 0 | - |
Dec 31, 2022 | 8 | 1 | 14.29% |
Dec 31, 2021 | 7 | 0 | - |
Dec 31, 2020 | 7 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Sandoz Group AG | 22,633 |
Telix Pharmaceuticals Limited | 234 |
Elekta AB (publ) | 4,718 |
Ryman Healthcare Limited | 7,700 |
Verano Holdings Corp. | 3,900 |
Vireo Growth Inc. | 490 |
Medexus Pharmaceuticals Inc. | 82 |
Mosaic ImmunoEngineering News
- 7 months ago - Mosaic ImmunoEngineering Agrees to Acquire Clinical Necroptosis Cancer Therapy Assets from Oncotelic Therapeutics, Inc. - Accesswire
- 1 year ago - Mosaic ImmunoEngineering Announces Issuance of U.S. Patent Covering Cancer Treatment with Its Lead Immuno-Oncology Candidate MIE-101 - Accesswire
- 2 years ago - UPDATE: Mosaic ImmunoEngineering's Academic Collaborators Awarded Grants Totaling $4.3 Million from NCI Focused on the Company's Novel Immuno-Oncology Platform - Accesswire
- 2 years ago - Mosaic ImmunoEngineering's Academic Collaborators Awarded Grants Totaling $4.3 Million from NCI Focused on the Company's Novel Immuno-Oncology Plat-form - Accesswire
- 2 years ago - Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University - Accesswire
- 3 years ago - Newly Published Data Further Support Mosaic ImmunoEngineering's Lead Immuno-Oncology Candidate MIE-101 in Combination with OX40 Checkpoint Treatment in Melanoma - Accesswire
- 3 years ago - Mosaic ImmunoEngineering's Lead Immuno-Oncology Candidate MIE-101 Highlighted in Keynote Presentation - Accesswire
- 3 years ago - Mosaic ImmunoEngineering Announces Upcoming Presentation at the 23rd Annual SoCalBio Conference - Accesswire